Eye Catching Stocks: Arch Coal Inc. (NYSE:ACI), Zynga Inc (NASDAQ:ZNGA), Microvision Inc. (NASDAQ:MVIS), Durata Therapeutics, Inc. (NASDAQ:DRTX), Territorial Bancorp Inc. (NASDAQ:TBNK)

Arch Coal Inc., (NYSE:ACI) a producer of the commodity in Appalachia and the western United States, rose the most in more than two months after reporting an increase in cash on hand and profit that beat analysts’ estimates. The company also said it had $1.05 billion of cash and short-term investments as of Sept. 30, almost $60 million more than at the end of the … Continue reading Eye Catching Stocks: Arch Coal Inc. (NYSE:ACI), Zynga Inc (NASDAQ:ZNGA), Microvision Inc. (NASDAQ:MVIS), Durata Therapeutics, Inc. (NASDAQ:DRTX), Territorial Bancorp Inc. (NASDAQ:TBNK)

Chris Lewis10/1410/14

Stock Runners: Repligen (NASDAQ:RGEN), Durata Therapeutics (NASDAQ:DRTX), Acadia Realty Trust (NYSE:AKR), International Game Technology (NYSE:IGT), DDR Corp. (NYSE:DDR)

Repligen Corp. (NASDAQ:RGEN) released its earnings data on Monday, 11 Aug 2014. The company reported $0.09 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.06 by $0.03. The company had revenue of $15.60 million for the quarter, compared to the consensus estimate of $14.90 million. During the same quarter in the prior year, the company posted $0.14 earnings per share. The company’s … Continue reading Stock Runners: Repligen (NASDAQ:RGEN), Durata Therapeutics (NASDAQ:DRTX), Acadia Realty Trust (NYSE:AKR), International Game Technology (NYSE:IGT), DDR Corp. (NYSE:DDR)

Chris Lewis09/0409/04

Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

The Medicines Company (NASDAQ:MDCO) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.07) by $0.01. The company had revenue of $177.20 million for the quarter, compared to the consensus estimate of $175.60 million. During the same quarter last year, the company posted ($0.21) earnings per share. The … Continue reading Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

John Bellich05/2705/27

Biotech Gainers: Cerus Corporation (NASDAQ:CERS), Omeros Corporation (NASDAQ:OMER), Durata Therapeutics Inc (NASDAQ:DRTX), Aastrom Biosciences Inc (NASDAQ:ASTM)

Cerus Corporation (NASDAQ:CERS) and a pharmaceutical unit of Nipro Corporation announced a collaboration agreement. The collaboration will lead to the development of efficient and easy-to-use disposable kit for red cells. The project will benefit from the proprietary technology of Nipro towards the creation a red cell disposable kit that suits the needs of small and large blood centers. Cerus Corporation (NASDAQ:CERS) stock performance was 7.55% … Continue reading Biotech Gainers: Cerus Corporation (NASDAQ:CERS), Omeros Corporation (NASDAQ:OMER), Durata Therapeutics Inc (NASDAQ:DRTX), Aastrom Biosciences Inc (NASDAQ:ASTM)

Adam Keintzel05/0605/06

Healthcare Watch List: Oncothyreon (NASDAQ:ONTY), Corcept Therapeutics Incorporated (NASDAQ:CORT), Aastrom Biosciences (NASDAQ:ASTM), Durata Therapeutics (NASDAQ:DRTX)

Corcept Therapeutics (NASDAQ:CORT) Director Longitude Venture Partners L.P sold 250,000 shares of the company’s stock on the open market in a transaction dated Friday, May 2nd. The stock was sold at an average price of $4.11, for a total value of $1,027,500.00. Corcept Therapeutics Incorporated (NASDAQ:CORT) rose 5.06% percent to $ 4.15 yesterday on volume of 319,314 shares. The intra-day range of the stock was … Continue reading Healthcare Watch List: Oncothyreon (NASDAQ:ONTY), Corcept Therapeutics Incorporated (NASDAQ:CORT), Aastrom Biosciences (NASDAQ:ASTM), Durata Therapeutics (NASDAQ:DRTX)

Colin Pettis05/0605/06

Biotech Unusual Volume: Capstone Therapeutics (OTCMKTS:CAPS), Xencor (NASDAQ:XNCR), Durata Therapeutics (NASDAQ:DRTX), Clovis Oncology (NASDAQ:CLVS)

Capstone Therapeutics Corp. (OTCMKTS:CAPS) and its joint venture affiliate, LipimetiX Development, LLC (“JV”), today will hold a conference call and webcast to provide an operating update, discuss the start of AEM-28 Phase 1 clinical studies and report financial results for the fiscal year 2013. Capstone Therapeutics Corp. (OTCMKTS:CAPS) stock performance was 4.00% in last session and finished the day at $0.260. Traded volume was 57,580.00million … Continue reading Biotech Unusual Volume: Capstone Therapeutics (OTCMKTS:CAPS), Xencor (NASDAQ:XNCR), Durata Therapeutics (NASDAQ:DRTX), Clovis Oncology (NASDAQ:CLVS)

Kristen Barton03/3103/31